0
Precision BioSciences, Inc. Banner Image

Precision BioSciences, Inc. has reached its limit for free report views

Work for Precision BioSciences, Inc.? Upgrade Your Profile and unlock all your responsibility reports.

Precision BioSciences, Inc.

  • Ticker DTIL
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Precision BioSciences, Inc. Logo Image
  • 201-500 Employees
  • Based in Durham, North Carolina
Precision BioSciences, Inc. is a clinical stage biotechnology company dedicated to improving life (DTIL) with its novel and proprietary ARCUS® genome editing platform. ARCUS is a highly specific and versatile genome editing platform that was designed with therapeutic safety, delivery, and control in mind. Using ARCUS, the Company’s pipeline consists of multiple “off-the-shelf” CAR T immunotherapyMore clinical candidates and several in vivo gene correction therapy candidates to cure genetic and infectious diseases where no adequate treatments exist.
Precision BioSciences, Inc.

Most Recent Responsibility Report

Precision BioSciences, Inc.
MOST RECENT 2022 ESG Report

Report Locked. Precision BioSciences, Inc. has reached its limit for free report views.

Precision BioSciences, Inc. does not currently have any hardcopy reports on ResponsibilityReports.com. Click the button below to request a report when hardcopies become available.

Request Information
Our service enables potential investors to review the most recent and archived Precision BioSciences, Inc. Sustainability Report, Precision BioSciences, Inc. Corporate Social Responsibility Report, Precision BioSciences, Inc. CSR Report, Precision BioSciences, Inc. Corporate Responsibility, Precision BioSciences, Inc. CR Report, Precision BioSciences, Inc. Citizenship Report, Precision BioSciences, Inc. ESG Report, and Precision BioSciences, Inc. Environmental Report online.
Precision BioSciences, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!